|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.89 USD | -1.30% |
|
+5.90% | +20.83% |
| Capitalization | 12TCr 11TCr 9.63TCr 9.18TCr 17TCr 11,73800Cr 17TCr 1,15500Cr 45TCr 5,57200Cr 46TCr 45TCr 19,41400Cr | P/E ratio 2026 * |
15.5x | P/E ratio 2027 * | 13.4x |
|---|---|---|---|---|---|
| Enterprise value | 18TCr 15TCr 14TCr 13TCr 25TCr 17,09900Cr 25TCr 1,68200Cr 65TCr 8,11700Cr 67TCr 65TCr 28,28000Cr | EV / Sales 2026 * |
0.44x | EV / Sales 2027 * | 0.41x |
| Free-Float |
71.18% | Yield 2026 * |
2.75% | Yield 2027 * | 2.86% |
Last Transcript: CVS Health Corporation
| 1 day | -1.30% | ||
| 1 week | +5.90% | ||
| Current month | +15.13% | ||
| 1 month | +27.87% | ||
| 3 months | +22.18% | ||
| 6 months | +23.24% | ||
| Current year | +20.83% |
| 1 week | 90.63 |  | 98.43 |
| 1 month | 76.1 | | 98.43 |
| Current year | 69.51 | | 98.43 |
| 1 year | 58.5 | | 98.43 |
| 3 years | 43.56 | | 98.43 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 17/10/2024 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 12/05/2025 |
David Falkowski
CMP | Compliance Officer | - | 01/07/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 01/03/2007 |
Anne Finucane
BRD | Director/Board Member | 73 | 20/01/2011 |
| Director/Board Member | 71 | 05/03/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.66% | 3.92% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.30% | +5.90% | +58.57% | +39.27% | 12TCr | |
| -2.24% | -2.80% | +9.73% | +52.42% | 9.38TCr | |
| -0.69% | -5.27% | -8.75% | +39.67% | 2.54TCr | |
| -1.43% | -1.46% | +1.68% | +12.34% | 2.05TCr | |
| -0.71% | -0.42% | +5.78% | +40.94% | 2.07TCr | |
| 0.00% | -1.57% | -17.91% | -20.92% | 2.05TCr | |
| -0.95% | +3.30% | +19.89% | +176.64% | 1.69TCr | |
| +0.26% | -9.06% | -1.11% | +33.74% | 1.51TCr | |
| +3.72% | +0.55% | +39.09% | +106.22% | 1.28TCr | |
| +0.62% | -0.32% | -26.79% | -14.98% | 1.16TCr | |
| Average | -0.27% | -1.11% | +8.02% | +46.53% | 3.6TCr | |
| Weighted average by Cap. | -1.08% | +0.49% | +22.66% | +44.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41TCr 35TCr 32TCr 31TCr 56TCr 39,26700Cr 57TCr 3,86300Cr 1,49500Cr 18,64100Cr 1,53600Cr 1,50300Cr 64,94300Cr | 43TCr 37TCr 33TCr 32TCr 59TCr 40,84400Cr 60TCr 4,01900Cr 1,55500Cr 19,38900Cr 1,59800Cr 1,56300Cr 67,55200Cr |
| Net income | 791.66Cr 681.22Cr 622.86Cr 594.27Cr 1.09TCr 76TCr 1.11TCr 7.47TCr 2.89TCr 36TCr 2.97TCr 2.91TCr 1,25600Cr | 922.51Cr 793.82Cr 725.81Cr 692.49Cr 1.27TCr 89TCr 1.29TCr 8.71TCr 3.37TCr 42TCr 3.46TCr 3.39TCr 1,46400Cr |
| Net Debt | 5.59TCr 4.81TCr 4.4TCr 4.19TCr 7.69TCr 5,36100Cr 7.82TCr 53TCr 20TCr 2,54500Cr 21TCr 21TCr 8,86700Cr | 5.23TCr 4.5TCr 4.12TCr 3.93TCr 7.2TCr 5,01900Cr 7.32TCr 49TCr 19TCr 2,38200Cr 20TCr 19TCr 8,30000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 95.89 $ | -1.30% | 87,98,380 |
| 14/26/14 | 97.15 $ | -0.98% | 92,99,641 |
| 13/26/13 | 98.11 $ | +3.11% | 1,25,52,652 |
| 12/26/12 | 95.15 $ | +3.18% | 1,28,02,558 |
| 11/26/11 | 92.22 $ | +1.84% | 1,20,24,381 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition